{"id":"https://openalex.org/W1875475589","doi":null,"title":"Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.","display_name":"Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.","publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W1875475589","mag":"1875475589","pmid":"https://pubmed.ncbi.nlm.nih.gov/14617793"},"language":"en","primary_location":{"id":"pmid:14617793","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14617793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064084499","display_name":"Tracy Ann Brooks","orcid":"https://orcid.org/0000-0002-1100-2437","observed_orcids":["https://orcid.org/0000-0002-1100-2437"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tracy A Brooks","raw_affiliation_strings":["Department of Pharmacology and Therapeutics and Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics and Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033083387","display_name":"Hans Minderman","orcid":"https://orcid.org/0000-0003-4987-9266","observed_orcids":["https://orcid.org/0000-0003-4987-9266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Minderman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003488323","display_name":"Kieran L. O\u2019Loughlin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kieran L O'Loughlin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059765364","display_name":"Paula J. Pera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula Pera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026444854","display_name":"Iwao Ojima","orcid":"https://orcid.org/0000-0002-3628-1161","observed_orcids":["https://orcid.org/0000-0002-3628-1161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iwao Ojima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049910941","display_name":"Maria R. Baer","orcid":"https://orcid.org/0000-0002-9499-1348","observed_orcids":["https://orcid.org/0000-0002-9499-1348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria R Baer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053765173","display_name":"Ralph J. Bernacki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralph J Bernacki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064084499","display_name":"Tracy Ann Brooks","orcid":"https://orcid.org/0000-0002-1100-2437","observed_orcids":["https://orcid.org/0000-0002-1100-2437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tracy Brooks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9999,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.85013633,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"2","issue":"11","first_page":"1195","last_page":"205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8679999709129333},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9739999771118164},{"id":"https://openalex.org/keywords/multidrug-resistance-protein-1","display_name":"multidrug resistance protein 1","score":0.8460000157356262},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.8759999871253967},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8799999952316284},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9350000023841858},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.8809999823570251},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-efflux","display_name":"drug efflux","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cytotoxicity-enhancement","display_name":"cytotoxicity enhancement","score":0.6290000081062317},{"id":"https://openalex.org/keywords/mdr-modulators","display_name":"MDR modulators","score":0.6869999766349792},{"id":"https://openalex.org/keywords/tras","display_name":"TRAS","score":0.5109999775886536},{"id":"https://openalex.org/keywords/microtubule-depolymerization","display_name":"microtubule depolymerization","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C512196","wikidata":"https://www.wikidata.org/wiki/Q4650095","display_name":"Abcg2","level":5,"score":0.8483572006225586},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.8039792776107788},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7594254612922668},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.7570093274116516},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.7293174266815186},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.6902433633804321},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6652886867523193},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.658282995223999},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6038332581520081},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.5465474128723145},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.5328472256660461},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.5180723667144775},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4711536169052124},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35920917987823486},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.341202974319458},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31926459074020386},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25724703073501587},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2459264099597931},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19598224759101868},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.17192009091377258},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1315915882587433},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12506088614463806},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12116056680679321},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.09971579909324646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09408754110336304},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.07196348905563354},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000070997","descriptor_name":"ATP Binding Cassette Transporter, Subfamily G, Member 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:14617793","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14617793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"mag:1875475589","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14617793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4243306459","display_name":"IRINOTECAN AND CYTARABINE IN ACUTE MYELOID LEUKEMIA","funder_award_id":"R21CA089938","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4601853418","display_name":"NON-PROTEIN AMINO ACIDS AND TAXOID ANTITUMOR AGENTS","funder_award_id":"R01GM042798","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G7010575523","display_name":"Drug Development and Cancer Treatments","funder_award_id":"T32CA009072","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7054990686","display_name":"DEVELOPMENT OF NEW SEMISYNTHETIC TAXANES","funder_award_id":"R01CA073872","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7109023141","display_name":"Broad Spectrum MDR Modulation in AML","funder_award_id":"R21CA098457","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000888465","display_name":"Roswell Park Cancer Center Support Grant","funder_award_id":"P30CA016056","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W77471785","https://openalex.org/W201908734","https://openalex.org/W1249439018","https://openalex.org/W1524954183","https://openalex.org/W1528245630","https://openalex.org/W1572719338","https://openalex.org/W1706395004","https://openalex.org/W1723032639","https://openalex.org/W1780912673","https://openalex.org/W1828787736","https://openalex.org/W1964420048","https://openalex.org/W1969795656","https://openalex.org/W1971175458","https://openalex.org/W1974625634","https://openalex.org/W1980132014","https://openalex.org/W1984686364","https://openalex.org/W1987561182","https://openalex.org/W2006434892","https://openalex.org/W2014020178","https://openalex.org/W2020441233","https://openalex.org/W2027344275","https://openalex.org/W2028533496","https://openalex.org/W2028674500","https://openalex.org/W2029733434","https://openalex.org/W2048424737","https://openalex.org/W2050767064","https://openalex.org/W2051540000","https://openalex.org/W2066108808","https://openalex.org/W2071025146","https://openalex.org/W2078664795","https://openalex.org/W2078865702","https://openalex.org/W2087070363","https://openalex.org/W2093695558","https://openalex.org/W2103885797","https://openalex.org/W2109689528","https://openalex.org/W2110790042","https://openalex.org/W2125695832","https://openalex.org/W2142024216","https://openalex.org/W2148664855","https://openalex.org/W2149535267","https://openalex.org/W2165070790","https://openalex.org/W2266572268","https://openalex.org/W2317297920","https://openalex.org/W2321387150","https://openalex.org/W2332420392","https://openalex.org/W2414672022","https://openalex.org/W2414957002","https://openalex.org/W2535387270"],"related_works":["https://openalex.org/W2105758671","https://openalex.org/W2189233826","https://openalex.org/W2078664795","https://openalex.org/W2063095520","https://openalex.org/W2071547598","https://openalex.org/W3002224776","https://openalex.org/W2108842980","https://openalex.org/W2091856435","https://openalex.org/W2024934506","https://openalex.org/W1996863509"],"abstract_inverted_index":{"Overexpression":[0],"of":[1,24,75,90,103,117,128,132,134,148],"ATP-binding":[2],"cassette":[3],"transport":[4],"proteins,":[5],"including":[6],"P-glycoprotein":[7],"(Pgp),":[8],"multidrug":[9],"resistance":[10,17],"(MDR)":[11],"protein":[12,18],"(MRP-1),":[13],"and":[14,34,60,130,136,155,170,173,207,216],"breast":[15],"cancer":[16],"(BCRP),":[19],"is":[20,64],"a":[21,70,88],"well-characterized":[22],"mechanism":[23],"MDR":[25,72,205],"in":[26,120,142,159,177],"tumor":[27],"cells.":[28],"Although":[29],"the":[30,41,99,104,181],"cytotoxic":[31],"taxanes":[32],"paclitaxel":[33,118],"docetaxel":[35],"are":[36],"substrates":[37,133],"for":[38,67,126,200],"Pgp-mediated":[39],"efflux,":[40],"semisynthetic":[42],"taxane":[43,105],"analogue":[44],"ortataxel":[45,63],"inhibits":[46,108],"drug":[47],"efflux":[48,172],"mediated":[49],"by":[50,97,187],"Pgp":[51,141],"as":[52,55,69,138,140,188,190,202],"well":[53,139],"as,":[54],"we":[56],"recently":[57],"demonstrated,":[58],"MRP-1":[59,135,154],"BCRP.":[61],"Nevertheless,":[62],"not":[65],"optimal":[66],"development":[68,201],"clinical":[71,203],"modulator":[73],"because":[74],"its":[76],"cytotoxicity":[77,119,131,176],"[corrected].":[78,192],"We":[79],"sought":[80],"to":[81,161,212],"identify":[82],"noncytotoxic":[83,91],"taxane-based":[84,92],"broad-spectrum":[85,165,204],"modulators":[86,206],"from":[87],"library":[89],"reversal":[93],"agents":[94],"(tRAs)":[95],"designed":[96],"eliminating":[98],"C-13":[100],"side":[101],"chain":[102],"molecule,":[106],"which":[107],"microtubule":[109],"depolymerization.":[110],"Twenty":[111],"tRAs,":[112,194],"selected":[113],"based":[114],"on":[115],"modulation":[116,127],"Pgp-overexpressing":[121],"MDA435/LCC6(mdr1)":[122],"cells,":[123],"were":[124],"studied":[125],"retention":[129],"BCRP":[137,158],"established":[143],"cell":[144,178],"lines":[145,179],"overexpressing":[146,180],"each":[147],"these":[149],"transporters.":[150],"Four":[151],"tRAs":[152,166],"modulated":[153,157,168],"17":[156],"addition":[160],"Pgp.":[162],"The":[163],"four":[164],"strongly":[167],"daunorubicin":[169],"mitoxantrone":[171],"enhanced":[174],"their":[175],"three":[182],"MDRs,":[183],"decreasing":[184],"IC(50)":[185],"values":[186],"much":[189],"97%":[191],"These":[193],"especially":[195],"tRA":[196],"98006,":[197],"have":[198],"promise":[199],"warrant":[208],"more":[209],"preclinical":[210],"analysis":[211],"determine":[213],"pharmacokinetic":[214],"interactions":[215],"efficacy.":[217]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}